Seeing Signs of Diabetes
Scientists estimate that patients with type 1 or type 2 diabetes have already lost 50 to 90 percent of their insulin-producing cells by the time their conditions are diagnosed. A new molecular tracer could provide the first clear view of these cells in the pancreas, helping doctors detect and treat diabetes far earlier.
The tracer was developed by Hank Kung, a scientist at the University of Pennsylvania. It binds to a receptor inside the cells and is tagged with a radioactive label that can be detected using positron emission tomography (PET).
Preliminary tests show that PET scans using the tracer can distinguish between rats with healthy levels of insulin-producing cells in the pancreas (glowing areas in the image at left) and rats whose insulin-producing cells have been chemically damaged.
“If we could see cell loss early, perhaps we could get patients started on therapy before there is irreversible damage,” says Dan Skovronsky, founder and CEO of Avid Radiopharmaceuticals, the Philadelphia company that is developing the tracer.
Keep Reading
Most Popular
DeepMind’s cofounder: Generative AI is just a phase. What’s next is interactive AI.
“This is a profound moment in the history of technology,” says Mustafa Suleyman.
What to know about this autumn’s covid vaccines
New variants will pose a challenge, but early signs suggest the shots will still boost antibody responses.
Human-plus-AI solutions mitigate security threats
With the right human oversight, emerging technologies like artificial intelligence can help keep business and customer data secure
Next slide, please: A brief history of the corporate presentation
From million-dollar slide shows to Steve Jobs’s introduction of the iPhone, a bit of show business never hurt plain old business.
Stay connected
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.